iHuman Inc. Sponsored ADR (NYSE:IH – Get Free Report) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 2,311 shares, a growth of 109.9% from the September 15th total of 1,101 shares. Based on an average daily trading volume, of 6,942 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the shares of the stock are short sold.
iHuman Trading Up 2.6%
Shares of NYSE IH traded up $0.03 during midday trading on Tuesday, reaching $1.18. The company’s stock had a trading volume of 2,731 shares, compared to its average volume of 10,751. iHuman has a one year low of $1.10 and a one year high of $3.01. The company has a market cap of $60.07 million, a price-to-earnings ratio of 19.59 and a beta of 0.04. The company has a 50 day moving average price of $1.22 and a 200 day moving average price of $1.44.
iHuman (NYSE:IH – Get Free Report) last issued its earnings results on Tuesday, September 29th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.07). The business had revenue of $25.52 million for the quarter, compared to the consensus estimate of $33.94 million. iHuman had a return on equity of 2.44% and a net margin of 3.06%.
Analyst Ratings Changes
Read Our Latest Research Report on IH
iHuman Company Profile
iHuman Inc (NYSE: IH) is a China-based education technology company that develops digital learning products for children and families. Its offerings are designed to support early childhood development and foundational learning through interactive content, mobile applications and other online services.
The company’s product portfolio includes applications and programs focused on Chinese-language learning, English, mathematics, storytelling, coding and music. Its services generally combine animated lessons, games, practice activities and age-appropriate educational content intended to make learning more engaging for young users.
iHuman was established in 2016 and is headquartered in China.
Featured Stories
- Five stocks we like better than iHuman
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.
